Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 8 , ISSUE 2 ( April-June, 2014 ) > List of Articles

RESEARCH ARTICLE

Ultrasound Features of the Formation of the Maternal-Placental Complex in Cases of Hyperandrogenism as Observed during the First and Second Trimesters of Pregnancy

Malysheva Olga, Toropkina Elena, Agarkova Luybov, Bukharina Irina, Logvinov Sergey

Keywords : Placenta,Hyperandrogenism,Ultrasound examination,Dopplerometry,Morphology

Citation Information : Olga M, Elena T, Luybov A, Irina B, Sergey L. Ultrasound Features of the Formation of the Maternal-Placental Complex in Cases of Hyperandrogenism as Observed during the First and Second Trimesters of Pregnancy. Donald School J Ultrasound Obstet Gynecol 2014; 8 (2):149-154.

DOI: 10.5005/jp-journals-10009-1350

License: CC BY-NC 4.0

Published Online: 01-06-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Olga M, Elena T, Luybov A, Irina B, Sergey L. Ultrasound Features of the Formation of the Maternalplacental Complex in Cases of Hyperandrogenism as Observed during the First and Second Trimesters of Pregnancy. Donald School J Ultrasound Obstet Gynecol 2014;8(2):149-154.


PDF Share
  1. Morphometric analysis of terminal villi and gross morphological changes in the placentae of term idiopathic intrautherine growth restriction. Tissue Cell 2012;44(4):214-219.
  2. The breadth of the placental surface but not the length is associated with body size at birth. Placenta 2012;33(8):619-622.
  3. Term and preterm placental pathologies associated with fetal growth restriction. Arch Gynecol Obstet 2010;282(5):487-492.
  4. Androgen excess disorders in women: polycystic ovary syndrome and other disorders. 2nd ed. Totowa, New Jersey: Humana Press 2006. p. 349-378.
  5. Doppler examination in the evaluation of outcomes in pregnancies complicated by fetal intrauterine growth retardation—is it enough? Clin Exp Obstet Gynecol 2012;39(2): 222-224.
  6. Hyperandrogenic disorders. Clin Obstet Gynec 1990;33(3):640-654.
  7. Value of Doppler sonography near team: can umbilical and uterine indices in low-risk pregnancies outcome? J Perinat Med 2012;12:1388-1394.
  8. Diagnosis and therapy of androgenization. Berlin: Diesbach Verglag 1992. p. 253-267.
  9. Reproducibility of first trimester three-dimensional placental measurements in the evaluation of early placental insufficiency. J Obstet Gynecol Can 2009;31(12):1144-1148.
  10. Doppler ultrasound of the maternal uterine arteries: disappearance of abnormal waveforms and relation to birthweight and pregnancy outcome. Acta Obstet Gynecol Scand 2000;79(8):631-634.
  11. Fetoplacental biometry and umbilical artery Doppler velocimetry in the overished adolescent model of fetal growth restriction. Am J Obstet Gynecol 2012;7:1266-1273.
  12. Utility of first trimester ultrasonography before 11 weeks of gestation. Obstet Gyn 2012;34(5): 1344-1354.
  13. The role of preterm placental calcification in high-risk pregnancy as a predictor of poor uteroplacental blood flow and adwerse pregnancy outcome. Ultrasound Med Biol 2012;38(6):1011-1018.
  14. Pathologic basis of improving the screening utility of 2-dimensional placental morphology ultrasound. Placenta 2012;33(10):845-849.
  15. Placental location and newborn weight. J Obstet Gynec Can 2012;34(4):325-329.
  16. The relationship of the location of the placenta and the indices of the fetus birth process. Acush Ginekol (Sofiia) 1990;29(2): 15-18.
  17. Three-dimensional ultrasound evaluation of the placenta. Placenta 2011;32(2): 105-115.
  18. Ultrasound in pregnancy. Emerg Med Clin North Am 2012;4:849-867.
  19. Placental weight for gestational age and adverse perinatal outcomes. Obstet Gynecol 2012;11(9):1199-1207.
  20. Ultrasonographic assessment of early pregnancy complications. Ultrasound and Early Pregnancy. In: Jukovic D, Jauniaux E, editors. London: Parthenon Publishing, 1996, p. 53-65.
  21. Transvaginal color Doppler assessment of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1991;77(3):365-369.
  22. Global reproductive health: is diagnostic ultrasound appropriate technology? Ultrasound Obstet Gynec 2012;40(2): 123-125.
  23. Fetal adrenal suppression due to maternal corticosteroid use: case report. Clin Res Pediatr Endocrin 2011;11(3):160-162.
  24. Prenatal administration of dexamethasone during early pregnancy negatively affects placental development and function in mice. J Anim Sci 2012; 7:244-248.
  25. Placental thickness in the second trimester. J Ultrasound Med 2012;32(2):213-218.
  26. Placental pathologies in fetal MRI with pathohistological correlation. Placenta 2009; 30(6):555-559.
  27. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction. Ultrasound Obstet Gynec 2009;33(5):524-529.
  28. Computerised assessment of placental calcification post ultrasound. Ultrasound Obstet Gynec 2012;1:1344-1350.
  29. Fetal venous Doppler in pregnancies with placental disfunction. J Maternal Fetal Neonatal Med 2012;8:6788-6794.
  30. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010;94(5):1805-1811.
  31. 3D/4D sonography moved prenatal diagnosis of fetal anomalies from the second to the first trimester of pregnancy. J Matern Fetal Neonatal Med 2012 May;251(5):433-455.
  32. Hyperandrogenism in women. In Rabe T, Grunwald K, Runnebaum B. Gynecological Endocrinology. New York, Springer-Verlad, 2001. p. 517-579.
  33. Prenatal exposure to androgens as a factor of fetal programming. Rev Med Chil 2006;134(1):101-108.
  34. Hyperandrogenic disorders. Clinic Obstet Gynec 1990; 33(3):25-29.
  35. Placental morphologic features and chronic surface vasculature at term are highly correlated with 3-dimensional sonographic measurements at 11 to 14 weeks. J Ultrasound Med 2012;33(2):1277-1282.
  36. Maternal androgen excess reduce placental and fetal weights, increases placental steroidogenesis and leads to long-term health effects in their female offspring. Am J Physiol Endocrin Metab 2012;9:1455-1464.
  37. Current aspects of obstetric ultrasound in the screening setting. Praxis 2012;14:1473-1480.
  38. Reproductive impact of polycystic ovary syndrome. Curr Opin Endocr Diabetes 2012;19(6):505-511.
  39. Conditions assotiated with placental dysfunction. Minerva Gynecol 2011;63(5):459-464.
  40. Placental weight and efficiency in regulation to maternal body mass index and the risk of pregnancy complications. Placenta 2012;33:611-618.
  41. Effect of placenta previa on fetal growth restriction and stillbirth. Arch Gynecol Obstet 2012;286(2): 295-298.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.